Literature DB >> 3779898

The phenotypic stability of altered hepatic foci: effects of withdrawal and subsequent readministration of phenobarbital.

S Hendrich, H P Glauert, H C Pitot.   

Abstract

Previous studies from this and a number of laboratories have demonstrated that the majority of both focal and nodular lesions which occur during the early phase of multistage hepatocarcinogenesis in the rodent disappear or 'remodel' upon removal of the promoting agent. Utilizing techniques of quantitative stereology we have found that many if not the majority of altered hepatic foci induced by initiation with diethylnitrosamine/partial hepatectomy and promoted for 4 months with phenobarbital disappear with little or no morphologic evidence of remodeling within 10 days after withdrawal from phenobarbital and do not reappear for a 6-month period thereafter. However, administration of phenobarbital in the diet following an interval period of 10, 20, 30 or 90 days in the absence of the promoting agent resulted in the reappearance of these focal lesions at the same or an increased numerical level. The volume occupied by these focal lesions, which reflects the total numbers of altered cells present in the liver, increased somewhat even during the interval absence of phenobarbital but increased dramatically upon readministration of the promoting agent. Rats fed only a semi-purified diet for 180 days following a 4-month period of phenobarbital promotion of initiated animals exhibited a greater number but only half the total volume of altered hepatic foci, as did rats fed a cereal-based diet only for 180 days. The cereal-based diet (NIH-07) may contain some unknown initiating and/or promoting factors responsible for this phenomenon. These studies present further evidence both for the reversible nature of the stage of promotion of hepatocarcinogenesis and the irreversible characteristic of the stage of initiation, as well as the importance of the composition of the diet utilized in models of multistage hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3779898     DOI: 10.1093/carcin/7.12.2041

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  Gamma-glutamyltranspeptidase-positive (GGT+) hepatocytes from carcinogen-treated rats isolated by magnetic beads.

Authors:  Y H Xu; G L Sattler; T Mitaka; J S Zhang; H C Pitot
Journal:  In Vitro Cell Dev Biol       Date:  1991-07

Review 2.  Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis.

Authors:  S Hendrich; H C Pitot
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Derivation of phenobarbital-responsive immortal rat hepatocytes.

Authors:  C Chiao; Y Zhang; D G Kaufman; W K Kaufmann
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

4.  Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains.

Authors:  Robert R Maronpot
Journal:  J Toxicol Pathol       Date:  2009-04-06       Impact factor: 1.628

Review 5.  Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat.

Authors:  H C Pitot; Y Dragan; L Sargent; Y H Xu
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

Review 6.  Progression: the terminal stage in carcinogenesis.

Authors:  H C Pitot
Journal:  Jpn J Cancer Res       Date:  1989-07

7.  An approach to the determination of the relative potencies of chemical agents during the stages of initiation and promotion in multistage hepatocarcinogenesis in the rat.

Authors:  H C Pitot; H A Campbell
Journal:  Environ Health Perspect       Date:  1987-12       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.